ABSTRACT
INTRODUCTION
Quantitative-competitive, reverse transcription polymerase chain reaction (QC-RT-PCR) has been generally accepted as a useful tool for the quantitation of mRNA transcripts; however, numerous research efforts continue to rely on what have been referred to as semiquantitative RT-PCR techniques to attempt quantitation of gene expression. The latter methods are limited by the following: tube-to-tube variation (6) , inability to identify arrival at the plateau phase of PCR (2) and the inability to compare mRNA transcripts that have been amplified with different primer pairs. Despite these limitations, there are salient reasons to simplify RT-PCR-based quantitation of mRNA transcripts. (i) The design, production and testing for efficacy of suitable competitors can be time-consuming. (ii) It can be difficult to achieve consistent RT-PCR results for low-abundance mRNAs, even with a good competitor, primarily due to the extreme sensitivity of PCR to initial-cycle kinetics and/or minute differences in delivery of the desired amounts of target and competitor templates. (iii) Final data acquisition requires separation of two PCR products, which is labor-intensive and potentially hazardous if radioisotopes are used.
Despite the technical difficulties involved in quantitative RT-PCR, the use of semiquantitative RT-PCR procedures is undermined by the risk of acquiring misrepresentative data, thus further necessitating development of a reliable method for quantitation of mRNA transcripts. To address this need, we have developed methods and procedures to quantitate relative amounts of mRNA transcripts in a reliable, workable manner. In this report, we define basic criteria for the design of internal RNA competitors that provide excellent reliability when used in single-tube RT-PCRs. Recommendations for the accurate delivery of templates are described for use with a novel single-tube RT-PCR protocol that incorporates a "hot start" for prevention of mis-priming in the critical first round of PCR cycling (9) . To our knowledge, the protocols we provide are the first to provide a wax-tablet-based hot start to a single-tube RT-PCR. The use of capillary electrophoresis (CE) for rapid separation of PCR products and laserinduced fluorescence (LIF) for sensitive detection provides a safe and reliable approach for product analysis. Overall, three steps in a QC-RT-PCR have been optimized and combined: (i) gene-specific cDNA synthesis to limit the cDNA population, (ii) hot-started, single-tube RT-PCRs and (iii) CE analysis of products. This combination has resulted in a rapid and precise analytical system for quantitation of mRNA in a competitive format. This system can be used to determine relative mRNA transcript levels that are altered following selected treatments either in vivo or in vitro. Here, we describe the application of these methods to the quantitation of perforin (a pore-forming, cytolytic protein) mRNA transcripts expressed by T lymphocytes infiltrating mouse-skin allografts.
MATERIALS AND METHODS

Target Primers
Two target primers, PA and PB, were selected to enable PCR amplification of a 198-bp product of 54% G/C content; these primers correspond to bases 665-684 and 844-863, respectively, of the mouse perforin gene (GenBank ® Accession No. M23182). The selected primer sites span an intron to prevent same-size amplification of potential residual genomic DNA following total RNA extractions. These primers, and those described below, were synthesized by the Mayo Clinic Molecular Biology Core (Rochester, MN, USA) with retention of the 5 ′ -protecting group (dimethoxytrityl) for subsequent purification with Oligonucleotide Purification Cartridges ™ (OPC; PE Applied Biosystems, Foster City, CA, USA).
RNA Competitor Design and Production
A 158-bp RNA internal competitor of 53% G/C content that can be primed for cDNA synthesis with primer PB and amplified with target primers PA and PB was constructed by subcloning an appropriate PCR product into expression vector pET-17xb (Novagen, Madison, WI, USA). To generate the PCR insert, an upstream primer consisting of (5 ′→3 ′ ) an Xba I site, primer PA and puc18 1334-1353 sequence (GenBank Accession No. A02710) was used with a downstream primer consisting of (5 ′→3 ′ ) a BamHI site, primer PB and puc18 1432-1451 sequence in a standard PCR with 10 ng puc18 template (Sigma Chemical, St. Louis, MO, USA). Following standard cloning procedures, the resultant PCR product was excised from a 2% NuSieve ® GTG ® agarose gel (FMC BioProducts, Rockland, ME, USA), purified with a QIAquick ™Gel Extraction Kit (Qiagen, Chatsworth, CA, USA) and subcloned into the Xba I/ BamHI site of pET-17xb to produce pET-Pcomp. Host cells were DH5 α™ (Novagen). Plasmid was extracted from an overnight culture with a Wizard ® Plus Minipreps DNA Purification System (Promega, Madison, WI, USA) and sequenced on a Model 373A Automated Sequencer (PE Applied Biosystems) to confirm insertion of the desired sequence (Mayo Molecular Biology Core).
Competitor Transcription Reactions
The competitive RNA was transcribed from 1 µ g of BamHI-digested pET-Pcomp using T7 RNA Polymerase and NTPs (Promega), following the suppliers recommended protocol. The newly synthesized RNA was subjected to a 5-min incubation at 75°C to inactivate T7 RNA polymerase, followed by a 30-min incubation with 20 U of RNase-free DNase (Boehringer Mannheim, Indianapolis, IN, USA) at 37°C to degrade the DNA template, and a 5-min incubation at 75°C to inactivate the DNase. The competitor RNA was separated from post-reaction components by passage through a Micro Scale Rapid Total RNA Extraction Kit (5 Prime →3 Prime, Boulder, CO, USA) according to the manufacturer's instructions (omitting the guanidium isothiocyanate step), aliquotted and stored at -70°C. The effective elimination of competitor DNA template was verified by RT-PCR amplification without reverse transcriptase. Before use in experiments, the RNA was quantitated by absorbance at 260 nm ( A 260 ), estimated by the average of triplicate spectrophotometric readings and diluted in Molecular Biology Grade Ultrapure Water (5 Prime → 3 Prime) to appropriate concentrations.
Total Target RNA Extraction
Extractions of total RNA were made with a Micro Scale RapidTotal RNA Extraction Kit. The sources for RNA were mouse orthotopic tail skin grafts (2 mm ×5 mm) transplanted to histoincompatible recipients according to the previously described method (1). C57BL/6 recipients of primary grafts from BALB.B donors received secondset allografts from B10.129 (21 M) donors. Second-set grafts were harvested one day before expected rejection and RNA was extracted. RNA pellets were redissolved in RNase-free water, and aliquots were stored at -70°C. At the time of the experiment, triplicate A 260 readings were averaged, and the appropriate dilutions were made with Molecular Biology Grade Ultrapure Water.
RNA Storage and Handling
Standard procedures for handling and storing RNA were rigorously followed. All reagents prepared in the laboratory, and all RNA dilutions, were made with Molecular Biology Grade Ultrapure Water. Both total RNA samples and competitor RNA were stored at -70°C in aliquots, and a single aliquot of each was thawed, quantified and used at the time of the experiment. Remaining RNA was either discarded (competitor RNA) or reserved for other purposes (target RNA).
To promote complete and homogeneous solution of RNAs, RNA samples were first pipetted up and down 40-50 times and allowed to incubate at room temperature for 30 min before aliquotting for spectrophotometric readings.
RT-PCR Protocol
The first-strand cDNA synthesis for both the target and the competitor was primed with the gene-specific primer PB. A cDNA synthesis mixture for a final reaction volume of 20 µ L/tube was prepared as a master mixture and aliquotted into a series (usually 5-9) of 0.5-mL PCR tubes (PE Applied Biosystems). The final reaction concentrations were 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 5 mM MgCl 2 and 0.25 mM each dNTP (Promega); 20 pmol of primer PB and 0.5 U of PRIME RNase INHIBITOR ™ (5 Prime → 3 Prime) were also added. A constant amount of specimen-derived total RNA, followed by an incrementally increasing number of copies of RNA competitor, were then added to the tubes. Each template was added to its designated tube in the maximum allowable volume with TRIPLE CHECK ® calibrated, aerosolresistant pipet tips (Bio 101, La Jolla, CA, USA). As a final step, four units of Moloney murine leukemia virus Reverse Transcriptase (M-MLV RT; Life Technologies, Gaithersburg, MD, USA) were added to each tube to pro -mote equivalent starting points for transcription from each template. One control tube received water instead of RNA templates; a second control received both templates but no reverse transcriptase. Synthesis of cDNA was performed in a Model 480 DNA Thermal Cycler (PE Applied Biosystems) with an initial incubation at 37°C for 15 min followed by 20 min at 42°C. Following cDNA synthesis, provision for a subsequent hot start PCR was made by addition of an AmpliWax ® PCR Gem 100 Pellet (PE Applied Biosystems) to each tube before incubation in the cycler at 100°C for 5 min. The latter incubation inactivated the M-MLV RT, while the melted wax tablet prevented evaporation from the reaction mixture. After removal of the tubes from the cycler and allowing the wax layer to set for 1 min, an upper layer of PCR mixture was added. This layer had a final volume of 80 µ L and consisted of 1.25 mM MgCl 2 , 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 20 pmol primer PA and 1.25 U of TaqDNA Polymerase (Promega). PCR cycling parameters were as follows: (i) one cycle of denaturation at 94°C for 5 min (to complete the inactivation of M-MLV RT and fully denature the cDNAs for the critical first cycle), annealing at 56°C for 30 s and extension at 72°C for 1 min; (ii) 29 cycles with denaturation at 94°C for 1 min and the same annealing and extension parameters and (iii) a final extension at 72°C for 7 min.
Capillary Electrophoretic Analysis
Before CE analysis, 1 µ L of post-PCR product was diluted in 20 µ L sterile water and stored at 4°C until analysis. The CE conditions used involved a 50-µ m internal diameter × 20-cm length to detector (27-cm total length) DB-17-Coated µ -Sil Capillary (J & W Scientific, Folsom, CA, USA). The capillary was fitted in a P/ACE ™car -tridge for use with a P/ACE Model 2100 (Beckman Instruments, Fullerton, CA, USA) equipped with a laser-induced florescence (LIF) dectector with detection at 520 nm. Excitation of the fluorescent intercalator was induced with a 488-nm argon laser (Beckman Instruments). The 1 ×TBE buffer (89 mM Tris-base, 89 mM boric acid, 2 mM EDTA) was brought to a pH of 8.6
with CsOH. Hydroxyethyl cellulose (HEC; Aldrich Chemical, Milwaukee, WI, USA) was added to the buffer to 1% (wt/vol) as a sieving matrix. The buffer was then filtered through a 0.8-µ m acetate filter (Nalgene ® ; Nalge Nunc International, Rochester, NY, USA) to avoid complexes that may foul the capillary. Immediately before use, 1 µ M YO-PRO™-1 (Molecular Probes, Eugene, OR, USA) was added as a fluorescent intercalator. Sample injection involved (i) a 3-s × 3.5-kV electrokinetic pre-injection with water, (ii) a 20-s × 2-kV electrokinetic sample injection and (iii)a 3-s water post-injection at 0.5 psi (5.4 nL vol) (7). The separation was carried out at 7.5 kV (277 V/cm; 9 µ A) for 10 min with the inlet functioning as the cathode and the outlet functioning as the anode (reversed polarity). The capillary temperature was thermostatically maintained at 20°C. The capillary was flushed with fresh (non-electrophoresed) separation buffer for 4 min (2 min pre-and 2 min post-electrophoresis) between electrophoresis of samples. Capillary regeneration was accomplished by flushing the capillary with methanol for 20 min and then equilibrating with separation buffer for an additional 20 min at the start of the day. A Hae III digest of pBR322 (Boehringer Mannheim) was diluted 1:100 in water and used as a DNA standard to gauge the performance of the capillary at the start of each day's experiments.
Data Processing
Following CE, peak areas were quantitated by Gold System Data Acquisition Software (Version 8.1; Beckman Instruments). The ratio of the integrated peak areas was used to calculate the relative amounts of target and internal competitor products in each tube. To compensate for different levels of YO-PRO-1 intercalation that are dependent on the lengths of the PCR products, the competitor peak area was multiplied by the ratio of the number of target base pairs/number of competitor base pairs. The log of the ratio of the adjusted competitor peak area/target peak area was plotted on the ordinate axis, and the log of the competitor copy number was plotted on the abscissa. This produced a linear plot, and the point zero on the ordinate axis (the log value at the point where target and internal control were present in a 1:1 molar ratio) was interpolated to yield the approximate number of the copies of competitor and, thus, the approximate number of copies of target mRNA/ng total RNA (12) .
RESULTS AND DISCUSSION
A reliable quantitative system for analysis of RNA transcripts is best accomplished by producing an RNA internal competitor that can be primed for cDNA synthesis and subsequently amplified with the same primers, and with a similar efficiency, as the target of interest. It has been observed by others that the primer sequences have the greatest effect on amplification efficiency, provided the sizes of the amplified sequences are under 1 kb (10, 14) . It has also been shown that the amplification efficiency of an RNA standard can be the same as that of its corresponding target even though the sequence between the shared primer binding sites is completely different (14) . However, while it may not be necessary to do so, we select competitors and targets with similar G/C content ratios and distribution to help avoid differences in transcription efficiency that could occur as a result of differences in secondary structure and to avoid differences in denaturation efficiencies in the PCR (8) . Intuitively, shorter target and competitor products have less opportunity for secondary structure differences than longer products, and it is well documented that decreasing the length of double-stranded (ds)DNA lowers its melting point (8) . Thus, we prefer competitor and target products that are 200 bp or less, even though longer products (300-400 bp) have been successfully used for quantitative, competitive PCR (4). The sharpness and singularity of peaks observed on CE electropherograms serve as indicators that both products are being synthesized to completion at the PCR level, since incomplete products would be manifested either in variable slopes on the "left" side of the peaks or in additional peaks.
However, despite precautions taken in design of competitors, final confirmation of matched amplification kinet -ics for target and competitor pairs must be determined experimentally. It is generally considered that any target/competitor pair will eventually reach a limiting value as template ratios drift from a 1:1 molar ratio, beyond which the kinetics of amplification are no longer similar enough to yield reliable data (8) . Fortunately, for quantitative purposes, it is the 1:1 molar ratio of templates that needs to be ascertained, thus the points on either side of the 1:1 molar ratio (in a workable range, i.e., ca. 50-fold-100-fold) are the critical points that must be experimentally demonstrated to be reliable.
Identical micro-environments can be provided throughout the entire procedure by using a single tube for (i) the cDNA synthesis from both target and competitor templates with the same gene-specific primer and (ii) the subsequent PCR. The use of a single genespecific primer to prime first-strand cDNA synthesis of both the target and the competitor in the same mixture vastly reduces background cDNA synthesis as the transcripts of interest are preferentially transcribed. The reduction of background cDNA synthesis enhances the ability to amplify low-abundance transcripts in the PCR stage. In addition, the use of total RNA as the target source in single-tube RT-PCR reduces the introduction of pre-amplification error by mimimizing template processing, prereaction quantitation and transfer steps. To facilitate unbiased amplification of both target and competitor during the critical initial cycle of the PCR, we have incorporated the use of wax tablets to provide a hot start for single-tube RTPCRs. Without a hot start, primers and TaqDNA polymerase have an opportunity to initiate synthesis of nonspecific templates while reactions are still at room temperature. These initial nonspecific products would be amplified throughout the PCR and confound the separation and analysis of final products by CE. The consistency and precision of the hot-started RT-PCRs presented here attest to their efficacy. The RNA competitor for perforin described in this report was designed to meet the following basic requirements for an effective competitor: (i) incorporation of target primer sites on the 5 ′ and 3 ′ends of vector sequence (target primer sites should be selected to span at least one intron, if possible); (ii) choice of lengths of target and competitor of 200 bp or less, and within 15-50 bp of one another, to promote unbiased amplification in the PCR while allowing for subsequent CE separation; and (iii)G/C content and distribution as similar as possible to those of the target. Internal competitors that are used in a single-tube, hot start RT-PCR protocol with target total RNA must also meet basic requirements for reproducibility and reliability; replicates of the same experiment should provide comparable estimations of copy number of target mRNA per ng of total RNA, and the target and competitor should amplify with similar kinetics. Replicate experiments provide an assessment of base-line error incurred during the entire procedure.
The kinetics of amplification are tested by use of various template/competitor ratios to determine if these variances affect the final determination of approximate copy number of target mRNA transcripts/ng of total RNA. This we accomplish by altering either the range of internal competitor concentration or amount of target template used in reactions. When the percent differences observed in a kinetic analysis are less than or equal to the percent differences observed in a replicate analysis, a competitor is deemed reliable for use with the investigated target/competitor ratios. It is difficult to place a true value on the difference in kinetics of amplification because this difference overlaps baseline error. A competitor that meets these requirements will not only be useful for estimating relative transcript levels, it will facilitate the estimation of absolute values of transcript copy number.
Three replicate assays of QC-RT-PCR amplification of perforin transcripts were carried out to determine the variance in the estimated copy number generated by independent amplifications. The templates used in these experiments were the RNA competitor for perforin and total RNA extracted from a tail-skin allograft that was in the process of rejection. The amount of target total RNA was held constant at 50 ng per reaction tube in each experiment, while the competitor for perforin was increased over a range from 10 4 -10 5.7 copies in four reactions. Figure 1 shows electropherograms resulting from CE analysis for the first of these assays. Figure 1A shows the electropherogram for an entire electrophoretic separation (total analysis time of 10 min). Unincorporated DNA primers from the RTPCRs are evident at approximately 5.25 min, while the competitor (158 bp) and target (198 bp) DNA products are evident at 7.75 and 8.4 min, respectively. The separation exhibited excellent baseline resolution of the peaks, which were then easily quantified by the data acquisition software. The total analysis time was approximately 12 min per sample, including 10 min for electrophoresis and 2 min to replace the separation matrix and regenerate the capillary. Sample analysis times could be shortened by decreasing the ionic strength of the separation buffer to 0.5 ×TBE and/or decreasing the concentration of HEC from 1% to 0.6% and separating the PCR products at a higher field strength (data not shown). However, a loss in electrokinetic injection capacity and a small loss of peak resolution accompanied this change. The perforin target and competitor DNA lengths differ by 40 bp, but templates differing in length by as little as 15 bp could be quantitated directly in the 150-200-bp size range under these separation conditions. Figure  1 , Panels B through E show the electrophoretic results from a series of RT-PCR amplifications where the concentration of the competitor RNA template was incrementally increased, focusing on the area of the electopherogram where the target and competitor DNA fragments migrated. Analysis of peak area ratios from four replicate electrophoetic analyses yielded a coefficient of variation (CV) from the standard deviation (SD) of 0.49% (data not shown). Figure 2 shows the resultant graphs plotting the log of adjusted competitor peak area/target peak area ratio against the log of the competitor copy number for all three assays. The approximate copy number of perforin transcripts per 134BioTechniques
Vol. 25, No. 1 (1998) Figure 2 . Linear graphs resulting from three independent, replicate QC-RT-PCR assays of perforin mRNA levels in a mouse-tail skin allograft. In each experiment (A, B and C), the target total RNA was held constant at 50 ng, and identical competitor ranges were used. The calculated approximate copy numbers of perforin mRNA transcript/ng of total RNA are 1350, 1420 and 1200 for experiments A, B and C, respectively. ng of total RNA was calculated to be 1350, 1420 and 1200 with a mean ±SD of 1323 ± 92 (CV 7.0%) (Figure 2 ). The observed linearity was deemed acceptable with r 2 values of 0.997, 0.988 and 0.995, respectively, for each of the replicates. This SD and percent SD compare favorably to those previously reported for CE-based quantitation of PCR products (11) . These previous experiments utilized homogeneous tissue culture cell lines as sources of RNA; it was shown that the percent standard errors in those experiments were inversely proportional to copy numbers per cell and ranged from 1.2%-12.5% (11) . Note that the target RNA in the experiments reported in this communication is expressed by infiltrating T cells that comprise only a minority of the cells in skin allografts. Assuming that quantitations in this and the previous report (11) produced comparable results in terms of copy numbers per cell, the variability reported here is comparable to that previously reported.
A clear advantage in the use of CEderived peak areas to estimate competitor/target ratios in these experiments is the quantitation of both products from a single reaction tube, where any differences in sampling volume will equally affect both competitor and target products. However, in semiquantitative methods, it is necessary to determine the total amount of a single PCR product, and such a determination is strongly affected by potential errors in handling independent samples. Also, an advantage associated with plotting a series of competitor/target ratios is the ability to determine whether proper amplification occurred within each reaction tube. An experimental error made in one of the reactions in a QC-RT-PCR series will manifest itself as a log ratio that deviates from the linear relationship calculated from all other data points. Such error could only be observed in semiquantitative procedures by means of very careful titration. Furthermore, the use of an internal competitor obviates the need to determine whether reactions have reached the plateau phase of PCR (3, 11, 15) .
The observed discrepancy among replicate analyses is likely the result of slight differences in template dilutions and/or deliveries to the reaction mixture. When the experimental end point is a peak area ratio of target and competitor products following a dual template-based amplification, slight differences in quantitation and/or handling of these templates are exacerbated dramatically in the final result. It is, therefore, critical that steps be taken to minimize the discrepancies that can occur in template quantitation and handling. We have found that the use of an average of three spectrophotometric readings ( A 260 ) for quantitation of both RNA templates is helpful, provided that sufficient template is available. It is also important that all spectrophotometric readings be taken just before RT-PCR since sample evaporation during storage will affect the final RNA concentration. Additionally, calibrated pipets should be used for preparation of template dilutions, and calibrated pipet tips should be used for transferring template volumes of 10 µ L or less (see Materials and Methods). All template deliveries should be made in as large a volume as possible. The care necessary in template quantitation and delivery underscores the importance of using a one-tube approach for both the cDNA synthesis step and subsequent PCR, thereby minimizing loss associated with numerous template transfers.
Differences in amount of starting cDNA have been shown to have a significant impact on reproducibility in semiquantitative RT-PCR assays (13) . Hence, as discussed above, it is imperative to experimentally demonstrate similar amplification kinetics when using varying ratios of members of a selected target/competitor pair. Three additional perforin QC-RT-PCR assays were performed varying the inital concentration of target RNA and/or ranges of competitor RNA. Separate perforin assays were performed with 60 and 30 ng of total target RNA from a second skin graft while keeping the internal competitor range from 7.8 × 10 3 copies-2.5 ×10 5 copies (Figure 3 , A and B, respectively). A third assay ( Figure 3C ) was performed with 72 ng of target RNA and a range of competitor increasing from 1.56 ×10 4 -5 ×10 5 copies. The approximate copy numbers of perforin mRNA transcripts per ng of total RNA calculated from this data ( Figure   136BioTechniques Vol. 25, No. 1 (1998) The appropriate range of competitor dilutions needed for a successful assay must be determined empirically. It is useful to perform an initial pilot over a wide range of internal standard copy numbers to first estimate the copy number of a particular transcript. Using this information, a more restricted range of competitor copy number with smaller increments can be defined, tested for reproducibility and implemented. We have observed that reproducible CE data can be obtained within a somewhat limited range by use of the integrated peak areas on either side of the point where target and competitor RNAs are present in a 1:1 molar ratio. This limitation of CE analysis is likely in addition to the target/template ratio limitations described above and has been noted by others (5, 11) . The reduction of number of samples in a given series that need to be amplified and quantitated is, of course, desirable. Tube reduction is particularly important when quantities of the sample RNA are limited, and it provides the added bonus of reducing experimental time and expense. The number of preliminary investigations required is generally not extensive, as one preliminary run normally suffices for the subsequent assay of many samples in the same or similar categories. In the course of QC-RT-PCR experiments, a significant change in transcription levels may first be observed when one fails to bracket the 1:1 molar ratio of target and competitor. In this event, it is a simple matter to determine the adjustments that need to be made on the basis of the first experiment. One "walks" through transitions in transcription levels in a manner similar to chromosome walking, using the information gained from one experiment to advance to the next. Finally, while separation of products on an agarose gel following a QC-RT-PCR is not necessary if CE analysis is used, gel electrophoresis makes it possible to select only the samples on either side of the cross-over point for CE analysis.
In addition to perforin, we have designed and tested RNA competitors according to the guidelines discussed above for mouse tumor necrosis factor-α , interleukin-2 and Fas-ligand. These competitors have also proven to be reliable by meeting the amplification criteria described in this report for perforin.
We routinely obtain r 2 values in the 0.995-1.00 range and consider that amplifications resulting in rounded values of less than 0.990 must be repeated. The analyses in which the initial concentrations of templates were varied without changing the estimated copy number are stringent and will only be successful when both templates (target and competitor) amplify with similar kinetics. While the predominant use for quantitation of mRNA transcripts is the acquisition of relative values, competitors that pass the kinetic tests described here will also allow the estimation of absolute values. Thus, reliable comparisons of transcript levels among different genes that amplify with different primers can be made. Future research will explore applicability of the QC-RT-PCR system outlined here for multiplex quantitative PCR. This will enable the analysis of two or three genes of interest simultaneously and/or permit direct comparison of transcription of genes of interest to the transcription of a housekeeping gene. The ability of CE to separate products that differ by only 15 bp offers a distinct advantage over agarose gel electrophoresis for separation of multiple products in a multiplex analysis.
